Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases.

Recently, many studies indicated that microRNAs (miRNAs) stably existed in various body fluids, including serum, plasma, saliva, and urine. Such miRNAs that exist in mammalian body fluids are known as circulating miRNAs, and they can transmit signals between cells and regulate intracellular gene expression. Currently, we barely understand the characteristics, sources, secretion, uptake, and functions of newly generated miRNAs. Particularly, it has been shown that certain types of circulating miRNAs can provide effective clinical data, suggesting their roles as novel biomarkers for the early detection of diseases such as cancers, cardiovascular diseases, and diabetes. Therefore, miRNAs have attracted much attention in academia for their promising applications in fundamental research and clinical diagnosis. This review summarizes some of the functional studies that have been conducted as well as the promising applications of circulating miRNAs, and we hope it will benefit other researchers in this field.

[1]  P. Kantoff,et al.  Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancer , 2013, The Prostate.

[2]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Yan Wang,et al.  Human Circulating MicroRNA-1 and MicroRNA-126 as Potential Novel Indicators for Acute Myocardial Infarction , 2012, International journal of biological sciences.

[4]  M. L. Hastings,et al.  Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells , 2010, PloS one.

[5]  J. Sundquist,et al.  Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2 , 2014, PloS one.

[6]  W. Wallace,et al.  Systems-level regulation of microRNA networks by miR-130 / 301 promotes pulmonary hypertension , 2022 .

[7]  M. Neri,et al.  miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  H. Mann,et al.  Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis , 2013, Annals of the rheumatic diseases.

[9]  U. Kutay,et al.  Nuclear Export of MicroRNA Precursors , 2004, Science.

[10]  J. Lebrun,et al.  Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. , 2013, Cellular signalling.

[11]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[12]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[13]  D. Tang,et al.  Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  Pick-Wei Lau,et al.  The Molecular Architecture of Human Dicer , 2012, Nature Structural &Molecular Biology.

[15]  Zhaoyong Li,et al.  A plasma microRNA panel for early detection of colorectal cancer , 2015, International journal of cancer.

[16]  G. Calin,et al.  Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes , 2015, Modern Pathology.

[17]  V. Adamo,et al.  Circulating miR‐22, miR‐24 and miR‐34a as Novel Predictive Biomarkers to Pemetrexed‐Based Chemotherapy in Advanced Non‐Small Cell Lung Cancer , 2013, Journal of cellular physiology.

[18]  C. Strassburg,et al.  Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection , 2015, PloS one.

[19]  Muneesh Tewari,et al.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.

[20]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[21]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[22]  E. Lianidou,et al.  Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. , 2013, The Journal of molecular diagnostics : JMD.

[23]  Yu Sun,et al.  Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer , 2012, PloS one.

[24]  Min Xu,et al.  Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study , 2011, Acta Diabetologica.

[25]  M. Martínez-Larrad,et al.  Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers , 2013, PloS one.

[26]  Chee Woon Wang,et al.  Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer , 2013, BMC Cancer.

[27]  Alicia Algeciras-Schimnich,et al.  Analysis of circulating microRNA: preanalytical and analytical challenges. , 2011, Clinical chemistry.

[28]  Ava Kwong,et al.  Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection , 2013, PloS one.

[29]  Clay B Marsh,et al.  Methodological challenges in utilizing miRNAs as circulating biomarkers , 2014, Journal of cellular and molecular medicine.

[30]  S. Juo,et al.  The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse , 2013, PloS one.

[31]  G. Goodall,et al.  Circulating microRNAs predict biochemical recurrence in prostate cancer patients , 2013, British Journal of Cancer.

[32]  Graham Ball,et al.  Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer , 2014, PloS one.

[33]  Longgui Wang,et al.  Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.

[34]  X. Yao,et al.  Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy , 2011, The Prostate.

[35]  Mei Zhao,et al.  Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection , 2014, PloS one.

[36]  George A Calin,et al.  A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients , 2014, Clinical Cancer Research.

[37]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[38]  Thomas Thum,et al.  Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device , 2014, European journal of heart failure.

[39]  A. Rustgi,et al.  Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2 , 2015, PLoS genetics.

[40]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[41]  R. Testa,et al.  MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications , 2015, Oncotarget.

[42]  Byoung-Tak Zhang,et al.  Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex , 2006, Cell.

[43]  J. Chang-Claude,et al.  Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. , 2013, Clinical chemistry.

[44]  Axel Benner,et al.  Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.

[45]  Torben Hansen,et al.  Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.

[46]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[47]  X. Chen,et al.  Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles , 2012, PloS one.

[48]  Qiu-lin Tang,et al.  Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. , 2014, Oncology reports.

[49]  Qinghua Xu,et al.  Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer , 2012, PloS one.

[50]  Jenny P. C. Chong,et al.  Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction , 2015, European journal of heart failure.

[51]  L. Huson,et al.  Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. , 2013, American journal of respiratory and critical care medicine.

[52]  Jun Yang,et al.  A panel of five circulating microRNAs as potential biomarkers for prostate cancer , 2012, The Prostate.

[53]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[54]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[55]  Bei Zhang,et al.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers , 2013, Tumor Biology.

[56]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[57]  H. Makino,et al.  Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. , 2015, Metabolism: clinical and experimental.

[58]  F. Hamdy,et al.  Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.

[59]  Patricia Soteropoulos,et al.  MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. , 2007, Cancer research.

[60]  Hugh S Markus,et al.  Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.

[61]  E. Kroh,et al.  Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels , 2013, PloS one.

[62]  Daniel G. Anderson,et al.  Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron–sulfur deficiency and pulmonary hypertension , 2015, EMBO molecular medicine.

[63]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[64]  Sophie Rome,et al.  Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization , 2014, Diabetes Care.

[65]  Y. Toiyama,et al.  Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer , 2016, Gastric Cancer.

[66]  Feng Jiang,et al.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer , 2010, Laboratory Investigation.

[67]  Hushan Yang,et al.  Prospective evidence of a circulating microRNA signature as a non-invasive marker of hepatocellular carcinoma in HBV patients. , 2014, Oncotarget.

[68]  Ying Zhu,et al.  MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers , 2014, BMC Cancer.

[69]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[70]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[71]  H. Lodish,et al.  MicroRNAs Induced During Adipogenesis that Accelerate Fat Cell Development Are Downregulated in Obesity , 2009, Diabetes.

[72]  Irene Moya,et al.  microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. , 2013, Oncology reports.

[73]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[74]  Jennifer A. Doudna,et al.  Dicer-TRBP complex formation ensures accurate mammalian microRNA biogenesis. , 2015, Molecular cell.

[75]  T. Stopka,et al.  Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum , 2014, BMC Cancer.

[76]  A. Schetter,et al.  Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.

[77]  D. Ichikawa,et al.  Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.

[78]  Most Mauluda Akhtar,et al.  Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis , 2016, Oncotarget.

[79]  T. Tuschl,et al.  Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers , 2014, Proceedings of the National Academy of Sciences.

[80]  Perry D Moerland,et al.  MiR423-5p As a Circulating Biomarker for Heart Failure , 2010, Circulation research.

[81]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[82]  C. Hamm,et al.  Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. , 2013, Journal of the American College of Cardiology.

[83]  F. He,et al.  Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction , 2014, Molecular and Cellular Biochemistry.

[84]  B. Burwinkel,et al.  Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.

[85]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[86]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[87]  X. Chen,et al.  Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis , 2011, International journal of cancer.

[88]  C. Spradley,et al.  Circulating miRNAs as Potential Marker for Pulmonary Hypertension , 2013, PloS one.

[89]  T. Kieffer,et al.  Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. , 2013, Endocrinology.

[90]  Xi Chen,et al.  A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.

[91]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[92]  P. Bassi,et al.  A circulating miRNA assay as a first-line test for prostate cancer screening , 2016, British Journal of Cancer.

[93]  O. Lingjaerde,et al.  Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment , 2014, Molecular oncology.

[94]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[95]  Federica Limana,et al.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.

[96]  R. Vyzula,et al.  Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer. , 2012, Cancer biomarkers : section A of Disease markers.

[97]  Y. Toiyama,et al.  Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer , 2014, Annals of surgery.

[98]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[99]  D. Stewart,et al.  miR-26a linked to pulmonary hypertension by global assessment of circulating extracellular microRNAs. , 2013, American journal of respiratory and critical care medicine.

[100]  Zhang Wei,et al.  Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis , 2012, Journal of Cancer Research and Clinical Oncology.

[101]  Sota Asaga,et al.  Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.

[102]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[103]  David J. Galas,et al.  Comparing the MicroRNA Spectrum between Serum and Plasma , 2012, PloS one.

[104]  P. Reddy,et al.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? , 2016, Biochimica et biophysica acta.

[105]  Hongbing Shen,et al.  A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer , 2014, British Journal of Cancer.

[106]  M. Abdellatif.  Differential Expression of MicroRNAs in Different Disease States , 2012, Circulation research.

[107]  T. Thum,et al.  MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure , 2015, European journal of heart failure.

[108]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[109]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[110]  C. Atreya,et al.  Differential profiling of human red blood cells during storage for 52 selected microRNAs , 2010, Transfusion.

[111]  P. Hougaard,et al.  Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression , 2012, Experimental diabetes research.

[112]  Shuang Huang,et al.  SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells. , 2014, Neoplasia.

[113]  Kristin M. French,et al.  Identification of Therapeutic Covariant MicroRNA Clusters in Hypoxia-Treated Cardiac Progenitor Cell Exosomes Using Systems Biology , 2015, Circulation research.

[114]  S. Tommasi,et al.  Male breast cancer: genetics, epigenetics, and ethical aspects. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[115]  F. B. Sørensen,et al.  Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer , 2015, British Journal of Cancer.

[116]  Yuan He,et al.  Molecular Sciences Circulating Microrna-19a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction , 2022 .

[117]  G. Illei,et al.  The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes , 2012, PloS one.

[118]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[119]  V. Cameron,et al.  Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients , 2013, European journal of heart failure.

[120]  Angélica Figueroa,et al.  Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer , 2012, Journal of Translational Medicine.

[121]  W. D. van Marken Lichtenbelt,et al.  Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity , 2016, Nature Communications.

[122]  Yang Yu,et al.  Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM , 2010, Oncogene.

[123]  Wei Zhang,et al.  Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. , 2012, Cancer letters.

[124]  E. Olson,et al.  Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.

[125]  G. Jicha,et al.  Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease , 2012, Experimental Neurology.

[126]  F. Hu,et al.  Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus , 2013, PloS one.

[127]  Inhibiting cyprinid herpesvirus-3 replication with CRISPR/Cas9 , 2016, Biotechnology Letters.

[128]  J. She,et al.  Biomarkers for type 1 diabetes. , 2008, International journal of clinical and experimental medicine.

[129]  Q. Cai,et al.  MiRNA‐199a‐3p: A potential circulating diagnostic biomarker for early gastric cancer , 2013, Journal of surgical oncology.

[130]  J. Peñalver,et al.  A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer , 2016, Oncotarget.

[131]  I. Touitou,et al.  Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis , 2014, Mediators of inflammation.

[132]  T. Leung,et al.  Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.

[133]  Frederick Luk,et al.  Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits , 2012, Molecular Cancer.

[134]  Heiner Boeing,et al.  Use of Multiple Metabolic and Genetic Markers to Improve the Prediction of Type 2 Diabetes: the EPIC-Potsdam Study , 2009, Diabetes Care.

[135]  D. Ichikawa,et al.  Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer , 2015, Gastric Cancer.

[136]  Lei Wang,et al.  Differentially Expressed Plasma MicroRNAs and the Potential Regulatory Function of Let-7b in Chronic Thromboembolic Pulmonary Hypertension , 2014, PloS one.

[137]  D. Aberle,et al.  Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[139]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[140]  W. Mao,et al.  Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy , 2012, Acta Pharmacologica Sinica.

[141]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[142]  Calum MacAulay,et al.  Pre-profiling factors influencing serum microRNA levels , 2014, BMC Clinical Pathology.